Skip to main content

Advertisement

Log in

Successful treatment of Kimura disease with benralizumab

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Data availability

Data is available on request from the authors.

References

  1. Sun QF, Xu DZ, Pan SH, Ding JG, Xue ZQ, Miao CS, Cao GJ, Jin DJ (2008) Kimura disease: review of the literature.  Intern Med J 38: 668–672. https://doi.org/10.1111/j.1445-5994.2008.01711.x

  2. Iwai H, Nakae K, Ikeda K et al (2007) Kimura disease: diagnosis and prognostic factors. Published online. https://doi.org/10.1016/j.otohns.2007.03.027

    Article  Google Scholar 

  3. Abuel-Haija M, Hurford MT (2007) Kimura disease. Arch Pathol Lab Med 131:650–651. https://doi.org/10.5858/2007-131-650-KD

    Article  PubMed  Google Scholar 

  4. Dhingra Harshi, Nagpal Ruchi, Baliyan SRAAsif (2019) Kimura disease: case report and brief review of literature. Med Pharamcy Rep 92:195–199. https://doi.org/10.15386/cjmed-1030

    Article  Google Scholar 

  5. Kinoshita M, Ogawa Y, Onaka M, Shimada S, Kawamura T (2021) Mepolizumab-responsive Kimura disease. J Allergy Clin Immunol Pract 9(7):2928–2930. https://doi.org/10.1016/j.jaip.2021.02.049

  6. Teraki Y, Terao A (2022) Treatment of Kimura Disease With Dupilumab. JAMA Dermatol. https://doi.org/10.1001/jamadermatol.2021.5885

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cyrus C. Hsia.

Ethics declarations

Ethics approval

NA.

Patient consent statement

Patient provided informed consent.

Permission to reproduce material from other sources

NA

Conflict of interest

The authors declare no competing interest.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Szeto, V.G., Chin-Yee, B., Dehghani, M. et al. Successful treatment of Kimura disease with benralizumab. Ann Hematol 101, 2099–2100 (2022). https://doi.org/10.1007/s00277-022-04873-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-022-04873-0

Navigation